{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:02:24Z","timestamp":1782277344557,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","award":["W81XWH-07-2-0067"],"award-info":[{"award-number":["W81XWH-07-2-0067"]}],"id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","award":["2689 EID 001"],"award-info":[{"award-number":["2689 EID 001"]}],"id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ebiom.2024.105332","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:21:30Z","timestamp":1726611690000},"page":"105332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trial"],"prefix":"10.1016","volume":"108","author":[{"given":"Anke","family":"Pagnon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Carre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Chautard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Raynal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Feroldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvon","family":"Modjarrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Vangelisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Mantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105332_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.ebiom.2024.105332_bib2","series-title":"Yellow fever","year":"2018"},{"key":"10.1016\/j.ebiom.2024.105332_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55619","article-title":"The effect of climate change on yellow fever disease burden in Africa","volume":"9","author":"Gaythorpe","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2024.105332_bib4","series-title":"Control of yellow fever: field guide (Scientific and Technical Publication No. 603)","year":"2005"},{"issue":"27","key":"10.1016\/j.ebiom.2024.105332_bib5","first-page":"269","article-title":"Vaccines and vaccination against yellow fever. WHO position paper -- June 2013","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ebiom.2024.105332_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64670","article-title":"The global burden of yellow fever","volume":"10","author":"Gaythorpe","year":"2021","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105332_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105332_bib8","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S1473-3099(19)30323-8","article-title":"Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study","volume":"19","author":"Domingo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105332_bib9","series-title":"Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines. treplacement of annex 2 of WHO technical report series, No. 872 and of the amendment to that annex in WHO technical report series, No. 964","year":"2012"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105332_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9060671","article-title":"What constitutes protective immunity following yellow fever vaccination?","volume":"9","author":"Mokaya","year":"2021","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105332_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/am.25.4.539-544.1973","article-title":"Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl Microbiol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105332_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105332_bib13","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1080\/21645515.2021.1891752","article-title":"Yellow fever virus vaccination: an emblematic model to elucidate robust human immune responses","volume":"17","author":"Bovay","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105332_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41598-017-00798-1","article-title":"Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination","volume":"7","author":"Kongsgaard","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2024.105332_bib15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3389\/fimmu.2017.00943","article-title":"Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans","volume":"8","author":"Burny","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105332_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat Immunol"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105332_bib17","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.vaccine.2021.02.033","article-title":"Next generation live-attenuated yellow fever vaccine candidate: safety and immuno-efficacy in small animal models","volume":"39","author":"Piras-Douce","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105332_bib18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.vaccine.2022.11.051","article-title":"Evaluation of safety and immuno-efficacy of a next generation live-attenuated yellow fever vaccine in cynomolgus macaques","volume":"41","author":"Piras-Douce","year":"2023","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.ebiom.2024.105332_bib19","first-page":"00406","article-title":"Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial","volume":"S1473-S3099","author":"Modjarrad","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105332_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4269\/ajtmh.1982.31.830","article-title":"Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence","volume":"31","author":"Henchal","year":"1982","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105332_bib21","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s007050050646","article-title":"Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins","volume":"144","author":"Falconar","year":"1999","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105332_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105332_bib23","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105332_bib24","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.4049\/jimmunol.1700083","article-title":"A\u00a0systems vaccinology approach reveals temporal transcriptomic changes of immune responses to the yellow fever 17D vaccine","volume":"199","author":"Hou","year":"2017","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105332_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01516-23","article-title":"Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination","volume":"98","author":"Mantel","year":"2024","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2024.105332_bib26","series-title":"sva: surrogate variable analysis","author":"Leek","year":"2022"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105332_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105332_bib28","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105332_bib29","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.1128\/IAI.73.12.8226-8236.2005","article-title":"Interferon-inducible protein 10, but not monokine induced by gamma interferon, promotes protective type 1 immunity in murine Klebsiella pneumoniae pneumonia","volume":"73","author":"Zeng","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105332_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1465-9921-8-80","article-title":"The role of IFN-gamma in regulation of IFN-gamma-inducible protein 10 (IP-10) expression in lung epithelial cell and peripheral blood mononuclear cell co-cultures","volume":"8","author":"Torvinen","year":"2007","journal-title":"Respir Res"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105332_bib31","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41590-022-01328-6","article-title":"Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses","volume":"23","author":"Hagan","year":"2022","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105332_bib32","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1073\/pnas.1921388117","article-title":"Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine","volume":"117","author":"Wec","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2024.105332_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/v9040077","article-title":"T\u00a0cell-mediated immunity towards\u00a0yellow fever virus and useful animal models","volume":"9","author":"Watson","year":"2017","journal-title":"Viruses"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T19:47:33Z","timestamp":1729108053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424003682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":33,"alternative-id":["S2352396424003682"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105332","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105332"}}